UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hepatitis B virus-associated diffuse large B-cell lymphoma: unique clinical features, poor outcome, and hepatitis B surface antigen-driven origin

Oncotarget, 2015-09, Vol.6 (28), p.25061-25073

2015

Volltextzugriff (PDF)

Role of Bruton's tyrosine kinase in B cells and malignancies

Molecular cancer, 2018-02, Vol.17 (1), p.57-57, Article 57

2018

Volltextzugriff (PDF)

Mechanisms and consequences of constitutive NF-κB activation in B-cell lymphoid malignancies

Oncogene, 2014-12, Vol.33 (50), p.5655-5665

2014

Volltextzugriff (PDF)

Role of BAFF/BAFF-R axis in B-cell non-Hodgkin lymphoma

Critical reviews in oncology/hematology, 2014-08, Vol.91 (2), p.113-122

2014

Volltextzugriff (PDF)

Safety and efficacy of chimeric antigen receptor (CAR)-T-cell therapy in persons with advanced B-cell cancers and hepatitis B virus-infection

Leukemia, 2020-10, Vol.34 (10), p.2704-2707

2020

Volltextzugriff (PDF)

Analysis of hepatitis B virus infection in 1424 patients with different pathological types of lymphoma (2018–2022): A real‐world, retrospective study

Cancer medicine (Malden, MA), 2024-05, Vol.13 (10), p.e7284-n/a

2024

Volltextzugriff (PDF)

Reactivation of hepatitis B virus after rituximab‐containing treatment in patients with CD20‐positive B‐cell lymphoma

Cancer, 2010-10, Vol.116 (20), p.4769-4776

2010

Volltextzugriff (PDF)

Both chronic HBV infection and naturally acquired HBV immunity confer increased risks of B-cell non-Hodgkin lymphoma

BMC cancer, 2019-05, Vol.19 (1), p.477-477, Article 477

2019

Volltextzugriff (PDF)

Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis

Annals of hematology, 2011-10, Vol.90 (10), p.1219-1223

2011

Volltextzugriff (PDF)

Molecular impact of selective NFKB1 and NFKB2 signaling on DLBCL phenotype

Oncogene, 2017-07, Vol.36 (29), p.4224-4232

2017

Volltextzugriff (PDF)

Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: Analysis from the Asia Lymphoma Study Group

European journal of cancer (1990), 2013-11, Vol.49 (16), p.3486-3496

2013

Volltextzugriff (PDF)

The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets

The Journal of pathology, 2015-01, Vol.235 (2), p.355-367

2015

Volltextzugriff (PDF)

Identification and impact of hepatitis B virus DNA and antigens in pancreatic cancer tissues and adjacent non-cancerous tissues

Cancer letters, 2013-07, Vol.335 (2), p.447-454

2013

Volltextzugriff (PDF)

Targeting B cell receptor signalling in cancer: preclinical and clinical advances

Nature reviews. Cancer, 2018-03, Vol.18 (3), p.148-167

2018

Volltextzugriff (PDF)

Unraveling the role of hepatitis B virus DNA integration in B-cell lymphomagenesis

British journal of cancer, 2024-10, Vol.131 (6), p.996-1004

2024

Volltextzugriff (PDF)

Pharmacologic Inhibition of MALT1 Protease by Phenothiazines as a Therapeutic Approach for the Treatment of Aggressive ABC-DLBCL

Cancer cell, 2012-12, Vol.22 (6), p.825-837

2012

Volltextzugriff (PDF)

Diffuse large B-cell lymphoma classification system that associates normal B-cell subset phenotypes with prognosis

Journal of clinical oncology, 2015-04, Vol.33 (12), p.1379-1388

2015

Volltextzugriff (PDF)

Serial evaluation of CD19 surface expression in pediatric B-cell malignancies following CD19-targeted therapy

Leukemia, 2020-11, Vol.34 (11), p.3064-3069

2020

Volltextzugriff (PDF)

Small hepatitis B virus surface antigen promotes malignant progression of hepatocellular carcinoma via endoplasmic reticulum stress-induced FGF19/JAK2/STAT3 signaling

Cancer letters, 2021-02, Vol.499, p.175-187

2021

Volltextzugriff (PDF)

CD19 chimeric antigen receptor-T cells in B-cell leukemia and lymphoma: current status and perspectives

Leukemia, 2019-12, Vol.33 (12), p.2767-2778

2019

Volltextzugriff (PDF)

The microenvironment in chronic lymphocytic leukemia (CLL) and other B cell malignancies: Insight into disease biology and new targeted therapies

Seminars in cancer biology, 2014-02, Vol.24, p.71-81

2014

Volltextzugriff (PDF)

Lipid Trait Variants and the Risk of Non-Hodgkin Lymphoma Subtypes: A Mendelian Randomization Study

Cancer epidemiology, biomarkers & prevention, 2020-05, Vol.29 (5), p.1074-1078

2020

Volltextzugriff (PDF)

Hepatitis B virus-induced hepatocellular carcinoma

Cancer letters, 2014-04, Vol.345 (2), p.216-222

2014

Volltextzugriff (PDF)

A phase 1 trial of SGN-CD70A in patients with CD70-positive diffuse large B cell lymphoma and mantle cell lymphoma

Investigational new drugs, 2019-04, Vol.37 (2), p.297-306

2019

Volltextzugriff (PDF)

1 – 25 von 63.292

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56.527)
Mit Volltextzugriff
(55.889)

Publikationsform

6 weitere anzeigen...

Weniger anzeigen...

Sprache

8 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(61.740)
Life Sciences & Biomedicine
(61.077)
Humans
(46.439)
Female
(20.956)
Male
(19.324)
Biological And Medical Sciences
(14.304)
Middle Aged
(13.996)
Hematology
(13.793)
Tumors
(13.423)
Animals
(13.230)
Medical Sciences
(12.970)
Aged
(11.665)
Adult
(11.177)
Apoptosis
(9.583)
Medicine
(8.839)
Mice
(8.818)
Cancer
(8.507)
Medicine & Public Health
(8.263)
Cell Line, Tumor
(7.991)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(51.184)
EZB Electronic Journals Library
(38.893)
Journals@Ovid
(29.467)
IngentaConnect Journals
(27.785)
IngentaConnect Journals
(14.477)
Springer journals
(12.028)
Publisher or Other Site
(9.791)
Nexis Uni
(7.761)
Nature
(7.661)
Wiley Online Library
(7.646)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(7.437)
Elsevier ScienceDirect Journals Complete
(6.820)
Wiley Online Library Full Collection 2018
(5.254)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(5.083)
Taylor & Francis Journals
(4.958)
Taylor & Francis Current Content Access
(4.390)
Taylor & Francis:Master (3349 titles)
(4.124)
Springer Book Series
(1.584)
Oxford journals
(1.423)
Oxford Journals 2020 Medicine
(1.260)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Hepatitis B virus-associated diffuse large B-cell lymphoma: unique clinical features, poor outcome, and hepatitis B surface antigen-driven origin

Role of Bruton's tyrosine kinase in B cells and malignancies

Mechanisms and consequences of constitutive NF-κB activation in B-cell lymphoid malignancies

Role of BAFF/BAFF-R axis in B-cell non-Hodgkin lymphoma

Safety and efficacy of chimeric antigen receptor (CAR)-T-cell therapy in persons with advanced B-cell cancers and hepatitis B virus-infection

Analysis of hepatitis B virus infection in 1424 patients with different pathological types of lymphoma (2018–2022): A real‐world, retrospective study

Reactivation of hepatitis B virus after rituximab‐containing treatment in patients with CD20‐positive B‐cell lymphoma

Both chronic HBV infection and naturally acquired HBV immunity confer increased risks of B-cell non-Hodgkin lymphoma

Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis

Molecular impact of selective NFKB1 and NFKB2 signaling on DLBCL phenotype

Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: Analysis from the Asia Lymphoma Study Group

The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets

Identification and impact of hepatitis B virus DNA and antigens in pancreatic cancer tissues and adjacent non-cancerous tissues

Targeting B cell receptor signalling in cancer: preclinical and clinical advances

Unraveling the role of hepatitis B virus DNA integration in B-cell lymphomagenesis

Pharmacologic Inhibition of MALT1 Protease by Phenothiazines as a Therapeutic Approach for the Treatment of Aggressive ABC-DLBCL

Diffuse large B-cell lymphoma classification system that associates normal B-cell subset phenotypes with prognosis

Serial evaluation of CD19 surface expression in pediatric B-cell malignancies following CD19-targeted therapy

Small hepatitis B virus surface antigen promotes malignant progression of hepatocellular carcinoma via endoplasmic reticulum stress-induced FGF19/JAK2/STAT3 signaling

CD19 chimeric antigen receptor-T cells in B-cell leukemia and lymphoma: current status and perspectives

Prophylactic antiviral therapy for hepatitis B virus surface antigen‐positive patients with diffuse large B‐cell lymphoma treated with rituximab‐containing chemotherapy

The microenvironment in chronic lymphocytic leukemia (CLL) and other B cell malignancies: Insight into disease biology and new targeted therapies

Lipid Trait Variants and the Risk of Non-Hodgkin Lymphoma Subtypes: A Mendelian Randomization Study

Hepatitis B virus-induced hepatocellular carcinoma

A phase 1 trial of SGN-CD70A in patients with CD70-positive diffuse large B cell lymphoma and mantle cell lymphoma

Aktive Filter

Suchergebnisse filtern